Cargando…
Pharmacoeconomic Analysis of Clopidogrel in Secondary Prevention of Coronary Artery Disease
BACKGROUND: When used as an alternative to or in addition to aspirin, clopidogrel has been demonstrated by some but not all randomized controlled trials to be effective in secondary prevention of cardiovascular (CV) events in patients with (1) coronary artery disease (CAD), (2) acute coronary syndro...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438004/ https://www.ncbi.nlm.nih.gov/pubmed/17506599 http://dx.doi.org/10.18553/jmcp.2007.13.4.326 |